Dr. Antonia Luisa Altomare, DO

Dr. Altomare practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Altomare's NPI, 1568688232, was assigned on April 18, 2007. Dr. Altomare graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2007. Dr. Altomare holds New Hampshire license 14697.

Dr. Altomare's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Altomare's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Altomare to 1 more medical group, named with a free account. Dr. Altomare's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Altomare practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Altomare's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Altomare is board certified in infectious disease by the American Board of Internal Medicine. Dr. Altomare is licensed in New Hampshire.

Dmand AI lists acute skin infection, hiv/aids, joint or bone infection and yeast infection among the conditions Dr. Altomare treats.

CMS data shows 95 Medicare services from Dr. Altomare across 3 procedure codes in 2024, for 82 Medicare patients. Medicare paid $10,148 for them.

CMS counts 82 Medicare patients who saw Dr. Altomare in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Altomare's median patient age at 54, with 39% women.

In 2024, Dr. Altomare wrote 470 Medicare Part D claims for 45 patients. 33% of them were for generic drugs. CMS names the drug for 322 of them, across 11 drugs with 11 or more claims each, at $842,824 in total drug cost. In 2023, CMS named 360 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Altomare for performance year 2024, reported through an alternative payment model (APM). Dr. Altomare accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Altomare as offering telehealth.

Dmand AI links 3 papers to Dr. Altomare, published from 2018 to 2024. 2024 was the busiest year, with 2. Dr. Altomare's most frequent co-authors are Matthew Alexander Roginski, MD and Richard A. Zuckerman, MD, MPH.

CMS Open Payments shows 1 general payment to Dr. Altomare from 1 drug or device company in 2019. Consulting fees make up the largest share, 100% of the total. Oxford Immunotec USA Inc paid the most, $1,200.

Dr. Altomare graduated from New York Institute of Technology College of Osteopathic Medicine - Old Westbury in 2007.

Dr. Altomare is in network with 6 carriers, including Excellus BlueCross BlueShield, Cigna and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.